About the Authors

Frank Stenner

Contributed equally to this work with: Frank Stenner, Heike Liewen

stennerf@uhbs.ch

Affiliation Division of Oncology, University Hospital Zurich, Zurich, Switzerland

Heike Liewen

Contributed equally to this work with: Frank Stenner, Heike Liewen

Affiliation Division of Oncology, University Hospital Zurich, Zurich, Switzerland

Stephan Göttig

Affiliation DRK Institute of Transfusion Medicine and Immune Hematology, Johann-Wolfgang Goethe University, Frankfurt am Main, Germany

Reinhard Henschler

Affiliation DRK Institute of Transfusion Medicine and Immune Hematology, Johann-Wolfgang Goethe University, Frankfurt am Main, Germany

Norbert Markuly

Affiliation Division of Oncology, University Hospital Zurich, Zurich, Switzerland

Sascha Kleber

Affiliation Division of Oncology, University Hospital Zurich, Zurich, Switzerland

Michael Faust

Affiliation Institute of Medical Biochemistry and Molecular Biology, University of the Saarland, Homburg/Saar, Germany

Axel Mischo

Affiliation Division of Oncology, University Hospital Zurich, Zurich, Switzerland

Stefan Bauer

Affiliation Medical Oncology Office, Lebach, Germany

Martin Zweifel

Affiliation Institute of Medical Oncology, Inselspital, Bern, Switzerland

Alexander Knuth

Affiliation Division of Oncology, University Hospital Zurich, Zurich, Switzerland

Christoph Renner

These authors also contributed equally to this work.

Affiliation Division of Oncology, University Hospital Zurich, Zurich, Switzerland

Andreas Wadle

These authors also contributed equally to this work.

Affiliation Division of Oncology, University Hospital Zurich, Zurich, Switzerland

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: FS HL CR AW. Performed the experiments: FS HL SG NM SK AW. Analyzed the data: FS HL SG NM SK CR AW. Wrote the paper: FS HL SG RH NM SK MF AM SB MZ AK CR AW. Participated in the critical data analysis and the final revision of the manuscript: FS HL SG RH NM SK MF AM SB MZ AK CR AW. Approved the final manuscript: FS HL SG RH NM SK MF AM SB MZ AK CR AW.